Yokoyama, Masahiro

Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. [electronic resource] - ISRN oncology 2013 - 863909 p. digital

Publication Type: Journal Article

2090-5661

10.1155/2013/863909 doi